Few Signs, Symptoms During Acute HIV-1 Infection

This article originally appeared here.
Share this content:
Few Signs, Symptoms During Acute HIV-1 Infection
Few Signs, Symptoms During Acute HIV-1 Infection

WEDNESDAY, May 18, 2016 (HealthDay News) -- Few symptoms and signs are observed during acute HIV-1 infection, and these are most common before peak viremia, according to a study published online May 18 in the New England Journal of Medicine.

Merlin L. Robb, M.D., from the Walter Reed Army Institute of Research in Silver Spring, Md., and colleagues performed twice-weekly qualitative plasma HIV-1 RNA nucleic acid testing in 2,276 volunteers at high risk for HIV-1 infection.

Fifty of 112 volunteers with acute HIV-1 infection had two or more blood samples collected before HIV-1 antibody detection. The researchers found that the median peak viremia occurred 13 days after nucleic acid testing reactivity appeared in the first sample. At a median of 14 days, reactivity on an enzyme immunoassay occurred. At a median of 31 days, the nadir of viremia occurred, which was nearly equivalent to the viral-load set point, the steady-state viremia that persists durably after viremia resolution. There was a correlation between peak viremia and downslope with viral-load set point. Just before and at the time of peak viremia, clinical manifestations of acute HIV-1 infection were most common. A median of one symptom of acute HIV-1 infection and one sign of acute HIV-1 infection were recorded at a median of two and three visits, respectively.

"During the acute phase, identification of cases of HIV-1 on the basis of clinical criteria may prove to be difficult," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »